A pre-IND meeting was held with the FDA and a protocol for Phase I clinical studies has been developed. A GMP manufacturer of the vaccine is now being contracted with to produce the material for the clinical study. A $5M+ Department of Defense grant was recently received to support the Phase I clinical program.
Cleveland Clinic doctor gets huge grant to continue breast cancer vaccine research
Breast cancer vaccine successful in mice
An autoimmune-mediated strategy for prophylactic breast cancer vaccination.
Targeted Vaccination against Human α-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast Cancer.